356 related articles for article (PubMed ID: 17568778)
1. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK.
Ryzhakov G; Randow F
EMBO J; 2007 Jul; 26(13):3180-90. PubMed ID: 17568778
[TBL] [Abstract][Full Text] [Related]
2. Functional dissection of the TBK1 molecular network.
Goncalves A; Bürckstümmer T; Dixit E; Scheicher R; Górna MW; Karayel E; Sugar C; Stukalov A; Berg T; Kralovics R; Planyavsky M; Bennett KL; Colinge J; Superti-Furga G
PLoS One; 2011; 6(9):e23971. PubMed ID: 21931631
[TBL] [Abstract][Full Text] [Related]
3. TRIM11 negatively regulates IFNβ production and antiviral activity by targeting TBK1.
Lee Y; Song B; Park C; Kwon KS
PLoS One; 2013; 8(5):e63255. PubMed ID: 23675467
[TBL] [Abstract][Full Text] [Related]
4. MAVS activates TBK1 and IKKε through TRAFs in NEMO dependent and independent manner.
Fang R; Jiang Q; Zhou X; Wang C; Guan Y; Tao J; Xi J; Feng JM; Jiang Z
PLoS Pathog; 2017 Nov; 13(11):e1006720. PubMed ID: 29125880
[TBL] [Abstract][Full Text] [Related]
5. E3 ubiquitin ligase ASB8 negatively regulates interferon via regulating TBK1/IKKi homeostasis.
Guo Y; Li R; Tan Z; Shi J; Fu Y; Song Y; Zhu M; Zhang L; Huang J
Mol Immunol; 2020 May; 121():195-203. PubMed ID: 32298923
[TBL] [Abstract][Full Text] [Related]
6. Identification of TBK1 complexes required for the phosphorylation of IRF3 and the production of interferon β.
Bakshi S; Taylor J; Strickson S; McCartney T; Cohen P
Biochem J; 2017 Mar; 474(7):1163-1174. PubMed ID: 28159912
[TBL] [Abstract][Full Text] [Related]
7. Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7.
Unterholzner L; Sumner RP; Baran M; Ren H; Mansur DS; Bourke NM; Randow F; Smith GL; Bowie AG
PLoS Pathog; 2011 Sep; 7(9):e1002247. PubMed ID: 21931555
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation.
Liu S; Cai X; Wu J; Cong Q; Chen X; Li T; Du F; Ren J; Wu YT; Grishin NV; Chen ZJ
Science; 2015 Mar; 347(6227):aaa2630. PubMed ID: 25636800
[TBL] [Abstract][Full Text] [Related]
9. Lysine 63-linked TANK-binding kinase 1 ubiquitination by mindbomb E3 ubiquitin protein ligase 2 is mediated by the mitochondrial antiviral signaling protein.
Ye JS; Kim N; Lee KJ; Nam YR; Lee U; Joo CH
J Virol; 2014 Nov; 88(21):12765-76. PubMed ID: 25142606
[TBL] [Abstract][Full Text] [Related]
10. Rabies virus P protein binds to TBK1 and interferes with the formation of innate immunity-related liquid condensates.
Scrima N; Le Bars R; Nevers Q; Glon D; Chevreux G; Civas A; Blondel D; Lagaudrière-Gesbert C; Gaudin Y
Cell Rep; 2023 Jan; 42(1):111949. PubMed ID: 36640307
[TBL] [Abstract][Full Text] [Related]
11. Regulation of IRF3 activation in human antiviral signaling pathways.
Al Hamrashdi M; Brady G
Biochem Pharmacol; 2022 Jun; 200():115026. PubMed ID: 35367198
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF.
Gatot JS; Gioia R; Chau TL; Patrascu F; Warnier M; Close P; Chapelle JP; Muraille E; Brown K; Siebenlist U; Piette J; Dejardin E; Chariot A
J Biol Chem; 2007 Oct; 282(43):31131-46. PubMed ID: 17823124
[TBL] [Abstract][Full Text] [Related]
13. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation.
Zhong B; Yang Y; Li S; Wang YY; Li Y; Diao F; Lei C; He X; Zhang L; Tien P; Shu HB
Immunity; 2008 Oct; 29(4):538-50. PubMed ID: 18818105
[TBL] [Abstract][Full Text] [Related]
14. Encephalomyocarditis virus 3C protease attenuates type I interferon production through disrupting the TANK-TBK1-IKKε-IRF3 complex.
Huang L; Xiong T; Yu H; Zhang Q; Zhang K; Li C; Hu L; Zhang Y; Zhang L; Liu Q; Wang S; He X; Bu Z; Cai X; Cui S; Li J; Weng C
Biochem J; 2017 Jun; 474(12):2051-2065. PubMed ID: 28487378
[TBL] [Abstract][Full Text] [Related]
15. PPM1A silences cytosolic RNA sensing and antiviral defense through direct dephosphorylation of MAVS and TBK1.
Xiang W; Zhang Q; Lin X; Wu S; Zhou Y; Meng F; Fan Y; Shen T; Xiao M; Xia Z; Zou J; Feng XH; Xu P
Sci Adv; 2016 Jul; 2(7):e1501889. PubMed ID: 27419230
[TBL] [Abstract][Full Text] [Related]
16. Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated?
Chau TL; Gioia R; Gatot JS; Patrascu F; Carpentier I; Chapelle JP; O'Neill L; Beyaert R; Piette J; Chariot A
Trends Biochem Sci; 2008 Apr; 33(4):171-80. PubMed ID: 18353649
[TBL] [Abstract][Full Text] [Related]
17. TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases.
Parvatiyar K; Barber GN; Harhaj EW
J Biol Chem; 2010 May; 285(20):14999-15009. PubMed ID: 20304918
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK.
Guo B; Cheng G
J Biol Chem; 2007 Apr; 282(16):11817-26. PubMed ID: 17327220
[TBL] [Abstract][Full Text] [Related]
19. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
tenOever BR; Sharma S; Zou W; Sun Q; Grandvaux N; Julkunen I; Hemmi H; Yamamoto M; Akira S; Yeh WC; Lin R; Hiscott J
J Virol; 2004 Oct; 78(19):10636-49. PubMed ID: 15367631
[TBL] [Abstract][Full Text] [Related]
20. Roles of an IkappaB kinase-related pathway in human cytomegalovirus-infected vascular smooth muscle cells: a molecular link in pathogen-induced proatherosclerotic conditions.
Gravel SP; Servant MJ
J Biol Chem; 2005 Mar; 280(9):7477-86. PubMed ID: 15619605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
